Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Pens Gene-Expression Alliance With Aussie Cancer Center

NEW YORK (GenomeWeb News) – Affymetrix today said that that it has penned a five-year gene-expression collaboration with the Peter MacCallum Cancer Centre in Australia.
 
Terms of the agreement call for Peter Mac researchers to use Affymetrix GeneChip technology for translational research projects. The first studies will cover ovarian cancer and carcinoma of unknown primaries.
 
Millennium Science will supply Peter Mac with Affy’s technology and provide technical support.
 
Financial details of the deal were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.